On May 2, 2023, the U.S. Food and Drug Administration (FDA) released Draft Guidance regarding the implementation of Decentralized Clinical Trials (DCTs) for drugs, biological products, and devices.

What is a Decentralized Clinical Trial?

DCTs are clinical trials where some or all trial-related activities occur at locations other than traditional clinical trial sites. Examples of…